Search

Search Constraints

You searched for: Author/Creator Ferrari, Angela

Search Results

1. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Issue 5 (May 2016)

2. Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS‐CoV‐2 positivity. Issue 1 (4th July 2020)

3. Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS‐CoV‐2 positivity. Issue 1 (4th July 2020)

4. Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS‐CoV‐2 positivity. Issue 1 (4th July 2020)

5. Clinical management of very small pigmented lesions: Improved clinical outcome through dermoscopy and reflectance confocal microscopy combination. Issue 5 (24th March 2020)

6. Comment on "Rescheduling of clinical activities and teleconsulting for public dermatology. Two prompt answers to COVID‐19 emergency". (25th July 2020)

7. Defining the best cut‐off value for lymphopenia in diffuse large B cell lymphoma treated with immuno‐chemotherapy. (3rd May 2014)

8. Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas. (14th December 2018)

9. Gene expression profile unveils diverse biological effect of serum vitamin D in Hodgkin's and diffuse large B‐cell lymphoma. Issue 2 (13th December 2020)

10. Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma. Issue 4 (17th June 2020)